Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells
Graphical abstract
Section snippets
Acknowledgments
We gratefully acknowledge the support from the University of Pisa (intramural research funds). This study was partially supported by the Edison Program of the State of Ohio and Ohio University Heritage College of Osteopathic Medicine.
References and notes (30)
- et al.
Cell
(2011) - et al.
Cancer Lett.
(2007) - et al.
Cancer Lett.
(2010) - et al.
Bioorg. Med. Chem. Lett.
(2010) - et al.
Eur. J. Med. Chem.
(2011) - et al.
J. Biol. Chem.
(2010) - et al.
Steroids
(1997) - et al.
J. Biol. Chem.
(2001) - et al.
ChemMedChem
(2012) - et al.
J. Nucl. Med.
(2009)
Expert Opin. Ther. Targets
Cancer
Sci. Transl. Med.
Chem. Pharm. Bull.
Mol. Cancer Ther.
Cited by (41)
Isosteres of ester derived glucose uptake inhibitors
2020, Bioorganic and Medicinal Chemistry LettersStructure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential
2020, European Journal of Medicinal ChemistrySynthesis of anti-4-phenoxyphenylaminoglyoxime and its some transition metal complexes: Spectral, DFT, electrochemical and anticancer activity studies
2020, Journal of Molecular StructureCitation Excerpt :Exploring the newly synthesized compounds and improving their biological activities by metal complexes appears to be crucial strategy to develop novel anticancer drugs. Recent evidences suggest that new oxime-based compounds could be evaluated as therapeutic agents for cancer therapy [24–29]. In light of this facts, at present study, we evauated the cytotoxic effects of our novel oxime ligand (LH2) and its metal complexes; Cu(LH)2 and Ni(LH)2, on MCF7 breast cancer cell line.
Solute carrier transporters: the metabolic gatekeepers of immune cells
2020, Acta Pharmaceutica Sinica BCitation Excerpt :While GLUT6 was previously reported to mediate glucose uptake in endometrial cancer cells65, at least in macrophages, the lysosomally located GLUT6 is not a true glucose transporter, and its physiological roles in immune cells still need to be clarified further64. The information reviewed above glucose transporters involved in immune cells are summarized in Table 166–86,87-119. Glutamine is one of the most abundant amino acids in circulation.
Glucose transport
2019, Stress: Physiology, Biochemistry, and Pathology Handbook of Stress Series, Volume 3Silencing of Glut1 induces chemoresistance via modulation of Akt/GSK-3β/β-catenin/survivin signaling pathway in breast cancer cells
2017, Archives of Biochemistry and BiophysicsCitation Excerpt :Therefore, Glut1 represents a potential therapeutic target for many cancers. Recent studies have focused on inhibiting Gluts to decrease cancer cell growth [22–25]. Basal-like breast cancers generally lack estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor 2 (HER2) on clinical assays and commonly referred to as “triple-negative” [26].